Drug search by name

Griseofulvin Microsize Oral Suspension and Lupus erythematosus

Result of checking the interaction of drug Griseofulvin Microsize Oral Suspension and disease Lupus erythematosus for safety when used together.

Check result:

Griseofulvin Microsize Oral Suspension <> Lupus erythematosus

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of griseofulvin has been associated with the development of lupus erythematosus and lupus-like syndromes, as well as exacerbation of the disease. Griseofulvin therapy should be withdrawn in patients experiencing worsening of preexisting lupus until another cause can be identified.

References:

Miyagawa S, Sakamoto K "Adverse reaction to griseofulvin in patients with circulating anti-ssa/ro and ssb/la autoantibodies." Am J Med 87 (1989): 99-102
Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K "Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin." J Am Acad Dermatol 21 (1989): 343-6
Madhok R, Zoma A, Capell H "Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin." Br Med J (Clin Res Ed) 291 (1985): 249-50
"Product Information. Fulvicin P/G (griseofulvin)." Schering Laboratories, Kenilworth, NJ.

Griseofulvin Microsize Oral Suspension

Generic Name: griseofulvin

Brand Name: Grifulvin V, Fulvicin P/G, Fulvicin U/F, Gris-PEG, Grisactin Ultra, Grisactin 250, Grisactin 500, Griseofulicin, Griseofulvic

Synonyms: Griseofulvin

What is Griseofulvin Microsize Oral Suspension?